Lans Holdings Inc (fka LAHO)

[ApollyonZ]

$LAHO..BofA..delay..death..market..worth at least $600 billion by 2025, according to one of Wall Street’s major investment banks.

..‘AMMORTALITY’

The “ammortality” theme, expected to be worth $504 billion by 2025, “will help to improve health spans & [lifespans] to the betterment of human vitality, enabling the world population to live freer of disease rather than forever.”

Companies that represent “ammortality” plays as described by BofA include health-care technology firms such as Intuitive Surgical and Zimmer, which worked with Apple Watch to start a clinical study for 10,000 knee and hip replacement

https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/



OXFORD

Human cells and tissues for transplantation can save lives or restore essential function

a corneal graft can restore sight in corneal blindness;
the transplantatin

https://www.who.int/transplantation/cell_tissue/en/

Adimarket, has announced an agreement with biotechnology company Alolotl Biologix

..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.

Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties

https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/

GSCG ISSCA Launch Dates.

•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212

Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/

State-Of-The-Art Equipment

We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..

http://stemcellslab.net/facility-and-equipment/

$LAHO $600B market ever increasing. Cash business, even when financed GSCG collects.